Philip Coover's questions to Tandem Diabetes Care Inc (TNDM) leadership • Q4 2024
Question
Philip Coover from Goldman Sachs questioned the OUS business outlook, noting that the 2025 guidance implies a slowdown in year-over-year growth, even after adjusting for the planned transition to direct sales and prior year one-time items.
Answer
Leigh Vosseller, Executive Vice President and Chief Financial Officer, acknowledged the various factors affecting the OUS business. She confirmed the 2025 guidance anticipates disruption from the transition to direct sales in select European countries ahead of a 2026 launch. She reiterated that outside of this disruption, the company feels strongly about the long-term growth opportunity in these underpenetrated markets.